1. Home
  2. MG vs TOI Comparison

MG vs TOI Comparison

Compare MG & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mistras Group Inc

MG

Mistras Group Inc

HOLD

Current Price

$15.34

Market Cap

531.0M

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$4.93

Market Cap

497.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MG
TOI
Founded
1978
2007
Country
United States
United States
Employees
N/A
641
Industry
Military/Government/Technical
Medical/Nursing Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
531.0M
497.9M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
MG
TOI
Price
$15.34
$4.93
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
178.8K
2.0M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$700,970,000.00
N/A
Revenue This Year
$5.47
$30.15
Revenue Next Year
$3.59
$25.77
P/E Ratio
$222.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.74
$2.32
52 Week High
$19.64
$6.67

Technical Indicators

Market Signals
Indicator
MG
TOI
Relative Strength Index (RSI) 32.47 42.80
Support Level $13.75 $4.90
Resistance Level $15.84 $5.63
Average True Range (ATR) 0.57 0.42
MACD -0.03 -0.12
Stochastic Oscillator 16.59 11.42

Price Performance

Historical Comparison
MG
TOI

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: